ŠÅŒìŽ¡—Ø_II •a‘Ô¶—ŠwŽŽŒ±–â‘è@@ŽR“cKG/–{“c’qŽq•½¬16”N(2004”N)11ŒŽ30“ú

³‰ð‚ðˆê‚‘I‚ÑC‚»‚̔Ԇ‚ðŠÅŒìŽ¡—Ø_II@“šˆÄ—pކ‚É‹L“ü‚µ‚ĉº‚³‚¢D

–â‘è1.ŒŒ‰t(blood)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1D“SŒ‡–R«•nŒŒ(iron deficiency anemia)‚ÍC³‹…«C’áF‘f«‚Ì•nŒŒ‚ðŽ¦‚·D

2D“SŒ‡–R«•nŒŒ‚Å‚ÍC•s–O˜a“SŒ‹‡”\‚͒ቺ‚·‚éD

3DĶ•s—Ç«•nŒŒ(aplastic anemia)‚ł͖–½ŒŒ‚ł͔ČŒ‹…Œ¸­(pancytopenia/•nŒŒanemiaC”’ŒŒ‹…Œ¸­leukocytopeniaCŒŒ¬”ÂŒ¸­thrombocytopenia)‚ðŽ¦‚·D

4DĶ•s—Ç«•nŒŒ‚Å‚ÍCŒŒ’†‚¨‚æ‚Ñ”A’†‚̃GƒŠƒXƒƒ|ƒGƒ`ƒ“(erythropoietin)”Z“x‚Í’á’l‚ðŽ¦‚·D

5. ”dŽí«ŒŒŠÇ“à‹ÃŒÅÇŒóŒQ(disseminated intravascular coagulation:DIC)‚Å‚ÍCŒŒ’†FDP (fibrin degradation products)’l‚͒ቺ‚·‚éD

 

–â‘è2DƒVƒ‡ƒbƒN(shock)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1DƒGƒ“ƒhƒgƒLƒVƒ“ƒVƒ‡ƒbƒN(endotoxin shock)‚̓Oƒ‰ƒ€‰A«ž…‹Û(Gram negative rod)‚Ì”sŒŒÇ(sepsis)Žž‚ɃOƒ‰ƒ€‰A«ž…‹Û‚©‚ç‚̃Gƒ“ƒhƒgƒLƒVƒ“(endotoxin)CƒŠƒ|ƒ|ƒŠƒTƒbƒJƒ‰ƒCƒh(lipopolysaccharide:LPS)‚ªŒ´ˆö‚ƂȂè‹N‚±‚éƒVƒ‡ƒbƒN‚Å‚ ‚éD

2DƒyƒjƒVƒŠƒ“‚𓊗^‚µ‚½‚Æ‚«‚ȂǂɋN‚±‚éƒyƒjƒVƒŠƒ“ƒVƒ‡ƒbƒN‚ÍRŒ´R‘Ì”½‰ž(antigen-antibody reaction)‚ÌŒ‹‰Ê‚É‚æ‚è¶‚¶‚邪C‚±‚̂Ƃ«ƒAƒiƒtƒBƒ‰ƒgƒLƒVƒ“(anaphylatoxin)‚ÍD‰–Šî‹…(basophil)‚â”ì–ž×–E(mast cell)‚âDŽ_‹…(eosinophil)‚Éì—p‚µ‚ÄCIgE‚âƒqƒXƒ^ƒ~ƒ“(histamine)‚Ȃǂð•úo‚³‚¹CŒŒŠÇ“§‰ß«(permeability)‚ð˜´i‚³‚¹C•½ŠŠ‹Ø(smooth muscle)‚ðŽûk‚³‚¹‚ăAƒiƒtƒBƒ‰ƒLƒV[ƒVƒ‡ƒbƒN(anaphylactic shock)‚ð‹N‚±‚·D

3D zŠÂŒŒ‰t—ÊŒ¸­«ƒVƒ‡ƒbƒN(hypovolemic shock)‚Ìê‡C•›t‘Ž¿(adrenal medulla)‚©‚çƒGƒsƒlƒtƒŠƒ“(epinephrine)Cƒmƒ‹ƒGƒsƒlƒtƒŠƒ“(norepinephrine)‚Ȃǂ̃JƒeƒR[ƒ‹ƒAƒ~ƒ“(catecholamine)‚ª•ª”傳‚ê––½ŒŒŠÇ‚ðŽûk‚³‚¹CŒŒˆ³‚ð㸂³‚¹‚é‹@˜‚ª“­‚­‚Ì‚ÅCƒVƒ‡ƒbƒN‚Ì‘Šú‚©‚ç”A—Ê(urine volume)‚ÍŒ¸­‚µ‚È‚¢D

4DS‹Ø[Ç(myocardial infarction)‚Ȃǂ̂Ƃ«‚É‹N‚±‚éSŒ´«ƒVƒ‡ƒbƒN(cardiogenic shock)‚Ìꇂɂ͑O•‰‰×(preload)‚ªŒ¸­‚·‚é‚̂Œ†SÖ¬ˆ³(central venous pressure)‚Í㸂µC‚¤‚ÁŒŒ«S•s‘S(congestive heart failure)‚ɂȂè‚â‚·‚¢D

5DƒVƒ‡ƒbƒN‚ÌꇂɂÍCŒŒ’†“ûŽ_(lactate)”Z“x‚Í㸂µC‰–Šî‰ßè(Base Excess)’l‚Í{(ƒvƒ‰ƒX)‚ƂȂéD

 

–â‘è3Dáu’É(pain)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1Dáu’ÉŠ´Šo‚ÍÒ‘Ž‹°˜H(spino-thalamic tract)‚ð‚Ö‚ÄŽ‹°(thalamus)‚É’B‚µC“à•ï(internal capsule)‚ðŒo‚Ä‘å”]”玿‚Ì’mŠo’†•‚É“ž’B‚·‚éD

2DƒAƒZƒ`ƒ‹ƒTƒŠƒ`ƒ‹Ž_(ƒAƒXƒsƒŠƒ“aspirin)‚̓sƒŠƒ“(pyrine)Œn‚̉ð”M’Á’ÉÜ(antipyretic analgesic drug)‚Å‚ ‚éD

3Dƒ‚ƒ‹ƒqƒl(morphine)‚Ì–ò—ì—p‚Æ‚µ‚Ä’Á’Éì—p(analgesic effect)C’ÁÃì—p‚ª‚ ‚èCŠà«áu’ɂɗp‚¢‚ç‚ê‚邪C’ÁŠPì—pCŽ~—Ÿì—p‚͂Ȃ¢D

4Dƒyƒ“ƒ^ƒ]ƒVƒ“(pentazocine)‚Ȃǂ̖ƒ–òhR«––½«’Á’É܂̓IƒsƒIƒCƒh(opioid)Žó—e‘̂ɓ­‚«C’Á’ÉŒø‰Ê‚ð”­Œ»‚³‚¹‚éD

5DƒAƒZƒ`ƒ‹ƒTƒŠƒ`ƒ‹Ž_(ƒAƒXƒsƒŠƒ“aspirin)‚Ȃǂ̔ñƒXƒeƒƒCƒh«R‰ŠÇÜ(non-steroidal anti-inflammatory drugs: NSAID)‚ÍƒŠƒ|ƒLƒVƒQƒi[ƒU(lipoxigenase)Šˆ«‚ð‘jŠQ‚µCƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“(prostaglandin),ƒgƒƒ“ƒ{ƒLƒTƒ“A2(thromboxane A2)‚Ȃǂ̎Y¶‚ð—}‚¦C‰ð”M’Á’Éì—p‚ðŽ¦‚·D

 

–â‘è4DŒÄ‹z•s‘S(respiratory failure)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1D V¶Ž™(newborn)‚ ‚é‚¢‚ͬl(adult)ŒÄ‹z‹‡”—ÇŒóŒQ(respiratory distress syndrome)‚ÌꇂɂÍPaO2‚̒ቺCPaCO2‚Ì㸂ª‚Ý‚ç‚ê‚邪CA-aDO2(”x–E‹C-“®–¬ŒŒŽ_‘f•ªˆ³Šr·)‚ͳí‚Å‚ ‚éD

2D ”x–E‹•’E(collapse)‚ª‚ ‚èC¶—“IƒVƒƒƒ“ƒg(shunt)‚ª‘‰Á‚µ‚Ä‚¢‚éê‡CŽ©”­ŒÄ‹z(spontaneous respiration)Žž‚ɌċCI––—zˆ³–@(positive end expiratory pressure: PEEP)‚ðs‚¤•û–@‚ðCPAP–@(continuous positive airway pressure)‚Æ‚¢‚¤‚ªCCPAP–@‚ÆŠE–ÊŠˆ«Ü(surfactant)‚ð—p‚¢‚Ä’áŽ_‘fŒŒÇ‚ðŽ¡—Ã‚·‚邱‚Æ‚ª‚ ‚éD

3D ƒAƒ`ƒh[ƒVƒX(acidosis)‚Ìê‡,@ ƒwƒ‚ƒOƒƒrƒ“‚ªŽ_‘f‚ð‰ð—£‚µ‚É‚­‚­‚È‚èAŽ_‘f‰ð—£‹Èü‚ªˆÚ“®‚µ‚ÄŽ_‘f–O˜a“x‚ª‰º‚ª‚邱‚Æ‚ðƒ{[ƒAŒø‰Ê(Bohr effect)‚Æ‚¢‚¤D

4D ƒ`ƒAƒm[ƒ[(cyanosis)‚ÍŒŒ’†‚ÌŠÒŒ³ƒwƒ‚ƒOƒƒrƒ“(deoxyhemoglobin)‚ª5g/dlˆÈã‚É‚È‚é‚ÆŒ»‚í‚ê‚é‚̂ŕnŒŒ(anemia)‚ª‚ ‚邯ƒ`ƒAƒm[ƒ[‚ÍŒ»‚í‚ê‚â‚·‚¢D

5D ”x–E–Ñ׌ŒŠÇƒuƒƒbƒNÇŒóŒQ(alveolar-capillary block syndrome, A-C block syndrome)‚ł͔x–E–Ñ׌ŒŠÇ–Œ‚ÌŒú‚³‚ª‘‘å‚·‚邽‚ߊgŽU(diffusion)‚ÌáŠQ‚ª‚ ‚ç‚í‚êC’áŽ_‘fŒŒÇ(hypoxia)‚Æ‚“ñŽ_‰»’Y‘fŒŒÇ(carbon dioxide retention)‚ɂȂéD

 

–â‘è5DS•s‘S(heart failure)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1DƒXƒƒ“-ƒKƒ“ƒc(Swan-Ganz)ƒJƒe[ƒeƒ‹–@‚É‚æ‚è‰EŽºŠg’£––Šúˆ³(right ventricle end-diastolic pressure)‚𑪒è‚Å‚«‚é‚Ì‚ÅC––½zŠÂ•s‘S‚Æ”x‚¤‚ÁŒŒ(lung congestion)‚Ì’ö“x‚ª‚í‚©‚éD

2DŠg’£Šú––Šú(end-diastolic)‚ÌSŽº—eÏ‚ª‘‚¦‚邯CSŽûk(contraction)—Í‚ª‚½‚©‚Ü‚è(inotropic action)C1‰ñS”o—Ê(stroke volume)‚¨‚æ‚ÑS””(heart rate)‚ª‘‰Á‚·‚錻Û(•ÏŽžì—p:chronotropic action)‚ðCƒtƒ‰ƒ“ƒNEƒXƒ^[ƒŠƒ“ƒO‚Ì‹@\(Frank-Starling mechanism/ƒXƒ^[ƒŠƒ“ƒO‚ÌS‘Ÿ‚Ì–@‘¥:Starling's law of heart)‚Æ‚¢‚¤D

3D‚¤‚ÁŒŒ«S•s‘S(congestive heart failure)‚ɂ͉ES•s‘S(right heart failure)‚ƶS•s‘S(left heart failure)‚Æ‚ª‚ ‚邪C‰ES•s‘S‚Ìꇂɂ͌ċz¢“ï(dyspnea)‚ªC¶S•s‘S‚Ìꇂɂ͕‚Žî(edema)‚ª‹N‚±‚éD

4DˆÙŠ«ŽhŒƒ(ectopic stimulus,impulse)‚Ì•”ˆÊ‚ªSŽº‚É‚ ‚éSŽº«ŠúŠOŽûk(ventricular extrasystole/‘ŠúŽûkventricular premature contraction:VPC)‚Ìꇂɂ͎hŒƒ‚ªŽhŒƒ“`“±Œn(conducting system)‚ð’Ê‚ç‚È‚¢‚Ì‚ÅS“d}(electrocardiogram)‚É‚¨‚¢‚ÄQRS•‚ªL‚­‚È‚éD

5D ƒAƒ_ƒ€ƒXEƒXƒg[ƒNƒXÇŒóŒQ(Adams-Stokes syndrome)‚ÌꇂÍCŠ®‘S–[ŽºƒuƒƒbƒN(complete atrio-ventricular block)CSŽº×“®(ventricular fibrillation)CSŽº‘e“®(ventricular flutter)‚Ȃǂɂæ‚è”]‹•ŒŒ‚ª‹N‚±‚èCޏ_”­ì(syncope)Cáz¹”­ì(convulsion)‚¨‚æ‚ђጌ“œ(hypoglycemia)”­ì‚Ȃǂª‚Ý‚ç‚ê‚éD

 

–â‘è6Dt(kidney)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. …‚ÌÄ‹zŽû‚ÍR—˜”Aƒzƒ‹ƒ‚ƒ“(antidiuretic hormone:ADH)‚É‚æ‚èC‰“ˆÊ”A׊ǂ¨‚æ‚ÑW‡ŠÇ‚É‚¨‚¢‚Äs‚È‚í‚êC”A—Ê(urine volume)‚ª’²ß‚³‚ê‚Ä‚¢‚éD

2. ”A׊NJî’ê–Œ‚É‚ÍNa+K+ŒðŠ·pump‚Æ‚¢‚¤“ñŽŸ”\“®—A‘—Œn(secondary active transporter)‚ª‚ ‚èCNa+‚Í×–E“à‚©‚猌ŠÇ“à‚Ö”\“®—A‘—‚³‚ê‚éD

3. ƒwƒ“ƒŒŒW’û‚Ì‘¾‚¢ãs‹r‚É‚ÍNa+K+2Cl-‹¤—A‘—‘Ì(cotransporter)‚Æ‚¢‚¤ˆêŽŸ”\“®—A‘—Œn(primary active transporter)‚ª‘¶Ý‚µCNa+K+‚ªÄ‹zŽû‚³‚êC2Cl-‚ª•ª”傳‚ê‚éD

4. –TŽ…‹…‘Ì‘•’u(juxstaglomerular apparatus)‚©‚çƒAƒ“ƒMƒIƒeƒ“ƒVƒ“(angiotensin)‚ª•ª”傳‚êCŒŒˆ³‚Ì’²ß‚ðs‚È‚Á‚Ä‚¢‚éD

5. ”A׊ǎ…‹…‘̃tƒB[ƒhƒoƒbƒN(tubuloglomerular feedback)‹@\[TGF‹@\]‚ÍŽ…‹…‘Ìàh‰ß—Ê‚¨‚æ‚Ñ…‚ÌÄ‹z—ʂ𒲮‚µCŒŒˆ³‚ðˆÀ’肳‚¹‚éƒVƒXƒeƒ€‚Å‚ ‚éD

 

–â‘è7D‘̉t(body fluid)C“d‰ðŽ¿(electrolyte)CŽ_‰–Šî•½t(acid-base balance)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. ”A—Ê‚Í2ml/kg/hr’ö“x‚Å‚ ‚éD

2. 1“ú‚É•K—v‚È…•ª—Ê(ml)‚Í200x‘Ìd(Kg)1/2‚Å‚ ‚éD

3. ƒAƒVƒh[ƒVƒX(acidosis)‚̂Ƃ«‚ɂ͂KŒŒÇ‚ɂȂè‚â‚·‚¢‚Ì‚ÅC•s®–¬‚ª‹N‚±‚è‚â‚·‚¢D

4. R—˜”Aƒzƒ‹ƒ‚ƒ“(antidiuretic hormone:ADH)•ª”åˆÙíÇŒóŒQ(syndrome of inappropriate secretion of ADH:SIADH/•s“KØR—˜”Aƒzƒ‹ƒ‚ƒ“•ª”åÇŒóŒQ)‚Ìê‡CADH•ª”å—Ê‚ªŒ¸­‚µ‚Ä‚¢‚邽‚ßCŒŒ‰t‚Í’áNaŒŒÇ‚ƂȂèC”A’†Na”Z“x‚Í㸂·‚éD

5. HCO3-”Z“x‚̒ቺ‚·‚é•a‘Ô‚ðŒÄ‹z«ƒAƒVƒh[ƒVƒX‚Æ‚¢‚¢CHCO3-”Z“x‚Ì‘‰Á‚·‚é•a‘Ô‚ðŒÄ‹z«ƒAƒ‹ƒJƒ[ƒVƒX‚Æ‚¢‚¤D

 

–â‘è8DƒAƒŒƒ‹ƒM[(allergy)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. ‘¦ŽžŒ^ƒAƒŒƒ‹ƒM[(immediate hypersensitivity)‚É‚¨‚¢‚Ĕ얞זE(mast cell)‚©‚ç‚Ì’Eè÷—±‚ÍIgER‘Ì‚ª‘¶Ý‚·‚ê‚ÎC”ì–ž×–E‚ÌIgEFcŽó—e‘Ì(receptor)‚̉ˋ´(crosslink)‚È‚µ‚Å‹N‚±‚éD

2. IgE‚ÌFc•”•ª‚ɑ΂·‚éŽó—e‘Ì‚ÍD’†‹…(neutrophil)C”ì–ž×–E(mast cell)CD‰–Šî‹…(basophil)CDŽ_‹…(eosinophil)‚Ì×–E•\–ʂɑ¶Ý‚·‚éD

3. IgGR‘Ì‚ÆC3a‚ð‰î‚·‚éƒIƒvƒ\ƒjƒ“Œø‰Ê(opsonization)‚ÍC3aŽó—e‘Ì(receptor)‚ðŽ‚ÂD’†‹…Cƒ}ƒNƒƒtƒ@[ƒW‚É‚¨‚¢‚Ä×–EáŠQŒ^(cytotoxic type/R‘̈ˑ¶Œ^antibody-mediated) ‚ðŽ¦‚·ƒAƒŒƒ‹ƒM[”½‰ž‚Å‚ ‚éD

4. R‘̈ˑ¶«×–EáŠQ(antibody-dependent cell-mediated cytotoxicity), ADCC‚ðŽ¦‚·ƒŠƒ“ƒp‹…‚Í(natural killer)×–E‚Å‚ ‚éD

5. ’x‰„Œ^ƒAƒŒƒ‹ƒM[(delayed type hypersensitivity/T×–E‰îÝ«‰ß•q”½‰žT cell mediated hypersensitivity )‚É‚¨‚¢‚Ä×–EáŠQ«T×–E(cytotoxic T lymphocyte)‚̓p[ƒtƒHƒŠƒ“(perforin)CƒOƒ‰ƒ“ƒUƒCƒ€(granzyme)‚ð•úo‚µC•W“I×–E‚̉óŽ€(necrosis)‚ð—U“±‚·‚éD

 

–â‘è9D ‘¹(injury)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1DŒŒŠÇ‚ª‘¹‚³‚ê‚邯‹ÃŒÅˆöŽq(coagulation factor)‚ªŠˆ«‰»‚³‚êüˆÛ‘f(ƒtƒBƒuƒŠƒ“fibrin)‚ªŒ`¬‚³‚ê‚Ä‹ÃW(agglutination)‚ª‚¨‚±‚éD

2D ”MƒVƒ‡ƒbƒN(burn shock)‚ÌꇂɂÍzŠÂŒŒ‰t—ÊŒ¸­«ƒVƒ‡ƒbƒN(hypovolemic shock)‚Ȃ̂Ŷ—“IH‰–…(physiological saline)‚ð—A‰t‚µ‹}«t•s‘S(acute renal failure)‚ð—\–h‚·‚邱‚Æ‚ª‘娂ł ‚éD

3D•¡ŽGœÜ(complex fracture)C”M(burn)CåñáŒ(decubitus)‚Ȃǂ̎¡—Â̂Ƃ«CŒÅ’…‚µ‚½‰˜õ‘gDC‰óŽ€‘gD‚𜋎‚·‚邱‚Æ‚ðƒfƒuƒŠƒhƒ}ƒ“(debridement)‚Æ‚¢‚¤D

4D ‘¢ŒŒ‘gD(hemopoietic tissue)‚Í•úŽËüáŠQ(radiation injury)‚ðÅ‚àŽó‚¯‚â‚·‚¢‚ªCƒŠƒ“ƒp‹…‚Í•úŽËü(radiation)‚ɑ΂µŠ´Žó«‚ª’á‚¢D

 

–â‘è10D•s®–¬(arrhythmia)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. S‘Ÿ‚ł͖[ŽºŒ‹ß‚©‚çC“´Œ‹ß‚Ö‚ÌŽhŒƒ‚ªCS–[CSŽº‚Ö‚Æ“`’B‚³‚ê‚Ä‚­D

2. •s®–¬‚É‚Í1•ªŠÔ100”ˆÈã‚Ì“´«•p–¬C50”ˆÈ‰º‚Ì“´«™–¬CŒÄ‹z‚Æ‹¤‚ɕϓ®‚·‚éŒÄ‹z«®–¬‚Ȃǂª‚ ‚éD

3. ㎺«ŠúŠOŽûk‚ÍSŽº‚©‚çŽhŒƒ‚ª”­¶‚µ‚Ä‚¢‚éD

4. SŽº«ŠúŠOŽûk(premature ventricular contraction:PVC)‚ª2‚‘±‚­‚à‚Ì‚ð“ñ’i–¬(bigeminy)C3‚‘±‚­‚à‚Ì‚ðŽO’i–¬(trigeminy)‚Æ‚¢‚¤D

5. SŽº×“®‚Å‚ÍS”o—ʂ͕ۂ½‚ê‚Ä‚¢‚éD

 

–â‘è11D•s®–¬(arrhythmia)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. “´Œ‹ß‚ÌŽhŒƒ”­¶‚ª‘½‚­‚È‚Á‚½‚èC“´Œ‹ß‚©‚çS–[‚Ö‚Ì“`’B‚ª˜´i‚·‚é‚·‚邱‚Ƃ𓴖[ƒuƒƒbƒN‚Æ‚¢‚¤D

2. –[ŽºŒ‹ß‚©‚ç‚Ì“`“±‚ªáŠQ‚³‚ꂽꇂ𓴖[ƒuƒƒbƒN‚Æ‚¢‚¤D

3. –[ŽºƒuƒƒbƒNCSŽº×“®‚ȂǕs®–¬‚ªŒ´ˆö‚ÅŽ¸_‚Ȃǂ̈ӎ¯áŠQ‚𶂸‚é‚Ì‚ðƒAƒ_ƒ€ƒXEƒXƒg[ƒNƒXÇŒóŒQ(Adams]Stokes syndrome)‚Æ‚¢‚¤D

4. 2˜A”­(paired ventricular premature beat)‚ÍS–[«ŠúŠOŽûk‚ª2ŒÂ˜A‘±‚µ‚Ä‚¢‚éD

5. ƒVƒ‡[ƒgƒ‰ƒ“(short run)Œ^SŽº«ŠúŠOŽû‚Å‚ÍSŽº«ŠúŠOŽûk(premature ventricular contraction:PVC)‚ª’f‘±“I‚É’ZŠúŠÔ‚Ý‚ç‚ê‚éD

 

–â‘è12DƒTƒCƒgƒJƒCƒ“(cytokine)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. ƒTƒCƒgƒJƒCƒ“‚É‚Íè÷—±‹…‚ªŽY¶‚·‚éƒCƒ“ƒ^[ƒŠƒ…[ƒLƒ“(interleukin:IL)CƒŠƒ“ƒp‹…‚ªŽY¶‚µC—V‘–(chemotaxis)‚ðˆø‚«‹N‚±‚·ƒPƒ‚ƒJƒCƒ“(chemokine)‚Ȃǂª‚ ‚éD

2. ƒTƒCƒgƒJƒCƒ“‚ÍƒŠƒ“ƒp‹…Cƒ}ƒNƒƒtƒ@[ƒWCŽ÷ó×–E(dendritic cell:DC)C‚¨‚æ‚Ñ‘¼‚Ì‘¢ŒŒŒn×–ECüˆÛ‰è×–ECƒPƒ‰ƒ`ƒmƒTƒCƒg‚ȂǎíX‚Ì×–E‚©‚çŽY¶‚³‚ê‚éC

3. ƒTƒCƒgƒJƒCƒ“‚ɑ΂·‚éŽó—e‘Ì(ƒŒƒZƒvƒ^[receptor)‚ÍCŠj‚É‘¶Ý‚·‚éŽó—e‘Ì‚ðŽ‚Â×–E‚Éì—p‚µ‚ÄC‚»‚Ì×–E‚Ì•ª‰»C‘BC‹@”\”­Œ»‚ð—U“±‚·‚é.

4. ƒCƒ“ƒ^[ƒtƒFƒƒ“(interferon:IFN)ƒ¿‚͉ŠÇ«ƒTƒCƒgƒJƒCƒ“‚Å‚ ‚èCŽîᇉ󎀈öŽq(tumor necrosis factor:TNF)ƒ¿CIL-1, IL-6‚Ȃǂ͖ƉuƒTƒCƒgƒJƒCƒ“‚Å‚ ‚éD

5. ƒwƒ‹ƒp[T×–E1Œ^(Th1)×–E‚̶¬‚É‚ÍIL-4‚ªCƒwƒ‹ƒp[T×–E2Œ^(Th2)×–E‚̶¬‚É‚ÍIL-12‚ªŠÖ—^‚µ‚Ä‚¢‚éD

 

 

 

–â‘è13DƒTƒCƒgƒJƒCƒ“(cytokine)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. T×–E‚̓TƒCƒgƒJƒCƒ“‚ðŽY¶‚·‚邪C‘åè÷—±ƒŠƒ“ƒp‹…(large granular lymphocyte:LGL/natural killer×–E)‚̓TƒCƒgƒJƒCƒ“‚ðŽY¶‚µ‚È‚¢.

2. ƒwƒ‹ƒp[T×–E(helper T cell)‚ÍCD4—z«‚Å‚ ‚èCƒTƒCƒgƒJƒCƒ“‚ðŽY¶‚·‚éD

3. ƒTƒCƒgƒJƒCƒ“‚̓wƒ‹ƒp[T×–E‚©‚ç‚à×–EáŠQ«T×–E(cytotoxic T lymphocyte: CTL)‚©‚ç‚àŽY¶‚³‚ê‚éD

4. ƒwƒ‹ƒp[T×–E1Œ^(Th1)×–E‚ÍIL-4, IL-6, IL-10‚ȂǂðŽY¶‚µCR‘ÌŽY¶‚Ì‘£i‚ƃAƒŒƒ‹ƒM[”½‰ž‚ÉŠÖ—^‚·‚éD

5. ƒwƒ‹ƒp[T×–E2Œ^(Th2)×–E‚ÍIL-2, IFNƒÁ‚ȂǂðŽY¶‚µC×–E«–Ɖu‚ÉŠÖ—^‚·‚é×–E‚̬n‚⊈«‰»‚𑣂·D

 

–â‘è14D×–E«–Ɖu(cellular immunity/×–E‰îÝ«–Ɖu cell-mediated immunity)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. ×–E«–Ɖu‚ÍTƒŠƒ“ƒp‹…iT×–Ej‚Å“`’B‚³‚ê‚éRŒ´“ÁˆÙ“I(antigen specific)Šl“¾–Ɖu(acquired immunity)‚ðŽw‚µC’x‰„Œ^ƒAƒŒƒ‹ƒM[”½‰ž(delayed type hypersensitivity), ×–EáŠQŠˆ«(cytotoxic activity)‚⓯ŽíˆÚA‹‘┽‰ž(allogeneic transplantation rejection reaction)‚ȂǂɊ֗^‚·‚éD

2. ƒwƒ‹ƒp[(helper)T×–E‚ÍB×–E‚ÌR‘ÌŽY¶‚ð—}§‚·‚éD

3. ×–EáŠQ«T×–E(cytotoxic T lymphocyte:CTL)‚ÍCD4RŒ´—z«‚Å‚ ‚éD

4. ƒCƒ“ƒ^[ƒtƒFƒƒ“ƒ¿(IFNƒ¿)‚ÍŒ‹Šj‹ÛCƒTƒ‹ƒ‚ƒlƒ‰‚ȂǂÌ×–E“àŠñ¶‘Ì‚ÌËÛì—p‚ƃ}ƒNƒƒtƒ@[ƒW‚Ì×–EŠQì—p‚ð‘‹­‚·‚éD

5. NK×–E‚ÍŽå—v‘gD“K‡ˆâ“`Žq•¡‡‘ÌMHC(major histocompatibility complex) Class II ‰A«‚̃EƒCƒ‹ƒXŠ´õ×–E‚âCŽîá‡×–E‚ðáŠQ‚·‚éD

 

–â‘è15D×–E«–Ɖu(cellular immunity/×–E‰îÝ«–Ɖu cell-mediated immunity)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. ×–EáŠQ«T×–E(cytotoxic T lymphocyte: CTL)‚̓EƒCƒ‹ƒXŠ´õ×–E(virus infected cell)‚ÍáŠQ‚µ‚È‚¢D

2. ×–EáŠQ«T×–E(cytotoxic T lymphocyte:CTL)‚ÍŠà×–E‚ÍáŠQ‚µ‚È‚¢D

3. ƒCƒ“ƒ^[ƒŠƒ…[ƒLƒ“(interleukin:IL-2/T×–E‘BˆöŽq, T cell growth factor:TCGF)‚ÍƒŠƒ“ƒp‹…‚Ì‘B‚ƖƉu‰ž“𔽉ž‚Ì‘‹­‚ð—U“±‚·‚éD

4. ×–EáŠQ«T×–ECTL‚ÍŽå—v‘gD“K‡ˆâ“`Žq•¡‡‘Ì(MHC) Class IIS‘©«‚Å‚ ‚éD

5. RŒ´ƒyƒvƒ`ƒh‚ÍRŒ´’ñަזE‚ÌŽå—v‘gD“K‡ˆâ“`Žq•¡‡‘Ì(MHC)‚Ƃ͕ʂÉCT×–ERŒ´Žó—e‘̂֒ñަ‚³‚ê‚éD

 

–â‘è16D’E…Ç(dehydration)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. ‘̉t‚ªŽ¸‚í‚ê‚éꇂÉC…‚Ì•û‚ª“d‰ðŽ¿‚æ‚葽‚­Ž¸‚í‚ê‚邯‘̉t‚ÌZ“§ˆ³”Z“x‚Í’á‚­‚È‚éD

2. •Ö‚ÌNa”Z“x‚ÍŒŒ´‚ÌNa”Z“x‚Ì1/2-1/3‚Å‚ ‚é‚Ì‚ÅC‹}Œƒ‚ɉº—Ÿ‚ª‹N‚±‚邯’á’£«’E…ǂƂȂéD

3. о‚ÌNa”Z“x‚ÍŒŒ´‚ÌNa”Z“x‚Ì1/3‚Å‚ ‚é‚Ì‚ÅC”­Š¾‚Ì‘‰Á‚ª‹N‚±‚邯’á’£«’E…ǂƂȂéD

4. ‚’£«’E…Ç‚Ìê‡C×–EŠO‰t‚ÌZ“§ˆ³‚ª‚‚¢‚Ì‚ÅC…‚Í×–E“à‚©‚ç×–EŠO‚ւƈړ®‚·‚邽‚ßzŠÂáŠQ‚ÌÇó‚ªo‚É‚­‚¢‚ªC×–E“à’E…‚ª‹­‚¢‚Ì‚ÅC•s‰¸C‹»•±Cáz¹C[•””½ŽË‚̘´i‚Ȃǂ̒†•_ŒoÇ󂪋­‚­oŒ»‚·‚éD

5. ’á’£«’E…Ç‚Ìê‡C×–EŠO‰t‚ÌZ“§ˆ³‚ª’á‚¢‚Ì‚ÅC…•ª‚Í×–EŠO‚©‚ç×–E“à‚ւƈړ®‚·‚邽‚ßzŠÂáŠQ‚ÌÇó‚ªo‚É‚­‚¢D

 

–â‘è17D”½ŽË’†•(reflex center)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. ŒÄ‹z’†•‚Í’†”]‚É‚ ‚éD

2. zŠÂ’†•‚Í‹´‚É‚ ‚éD

3. šq“f’†•‚Í’†”]‚É‚ ‚éD

4. ‘ÎŒõ”½ŽË’†•‚Í’†”]‚É‚ ‚éD

5. ”r”A’†•‚͉„‘‚É‚ ‚éD

 

–â‘è18D”r”A(micturition)‚ÉŠÖ‚µ³‚µ‚¢‚̂͂ǂê‚Å‚·‚©D

 

1. œ”Õ_Œo‚ÍŒðŠ´_Œo‚Å‚ ‚éD

2. ‰º• _Œo‚Í•›ŒðŠ´_Œo‚Å‚ ‚éD

3. ƒ¿Žó—e‘Ì‚ªŽhŒƒ‚³‚ê‚邯CäNã÷‚©‚ç‚Ì”A”rŸ•‚Í‘£i‚³‚ê‚éD

4. ƒÀŽó—e‘Ì‚ªŽhŒƒ‚³‚ê‚邯CäNã÷‚©‚ç‚Ì”A”rŸ•‚Í‘£i‚³‚ê‚éD

5. •›ŒðŠ´_Œo‚̃€ƒXƒJƒŠƒ“«ƒAƒZƒ`ƒ‹ƒRƒŠƒ“Žó—e‘Ì(muscarinic acetylcholine receptor)‚ªŽhŒƒ‚³‚ê‚邯”r”A‚ª‚¨‚±‚éD

 

–â‘è19D‘å”]“ª’¸•”i’†Sa•t‹ßj‚É’†`¬‹K–͂̓ªŠW“àoŒŒ‚ª‹N‚±‚Á‚½ê‡‚É”­Ç‚·‚é‰Â”\«‚Ì­‚È‚¢Çó‚͂ǂê‚Å‚·‚©D

 

1. ‰^“®–ƒáƒ

2. š‹‰º¢“ï

3. áz¹

4. һՃ

5. ˆÓޝáŠQ

–â‘è20D_ŒoÇó‚Æ‚µ‚ij‚µ‚¢‚à‚̂͂ǂê‚Å‚·‚©D

 

1. ”]в•”‚ªáŠQ‚³‚ꂽꇂÍA1‘¤‚̕Жƒáƒ‚Æ“¯‘¤‚Ì”]_Œo–ƒáƒ‚ªoŒ»‚·‚éD

2. Ž©•ª‚Ì–¼‘OA¶”NŒŽ“ú‚ªŒ¾‚¦‚È‚¢ˆÓޝáŠQ‚Ì‚ ‚銳ŽÒ‚ðJapan Coma Scale‚Ì…Ÿ-2‚Æ ”»’肵‚½D

3. “ªŠW“àoŒŒ‚ÅAŽ‹—ÍáŠQ‚ð‹N‚±‚·ê‡‚ª‚ ‚éD

4. Ž‹_Œo‚ªáŠQ‚³‚ê‚邯‚߂܂¢‚ªoŒ»‚·‚éD

5. ”½‰ñ_Œo–ƒáƒ‚É‚æ‚èA‰^“®«Ž¸Œê‚ªoŒ»‚·‚éD

 

Љԏ1

3

Љԏ2

1

Љԏ3

1

Љԏ4

2

Љԏ5

4

 

 

 

 

 

 

 

 

 

 

Љԏ6

1

Љԏ7

3

Љԏ8

4

Љԏ9

3

Љԏ10

2

 

 

 

 

 

 

 

 

 

 

Љԏ11

3

Љԏ12

2

Љԏ13

2

Љԏ14

1

Љԏ15

3

 

 

 

 

 

 

 

 

 

 

Љԏ16

4

Љԏ17

4

Љԏ18

5

Љԏ19

2

Љԏ20

3

 

------------0xKhTmLbOuNdArY Content-Disposition: form-data; name="userfile"; filename=""